Health Board/Region: Cardiff & Vale University Health Board Main Hospital Base: University Hospital of Wales, Llandough. Date of review: 28 June 2018
|
|
- Warren Fletcher
- 5 years ago
- Views:
Transcription
1 Peer Review: Cancer Sub-site: Breast Health Board/Region: Cardiff & Vale University Health Board Main Hospital Base: University Hospital of Wales, Llandough Cycle: Second Date of review: 28 June 2018
2 REVIEWEES SERVICE DESCRIPTION KEY THEMES STRUCTURE AND FUNCTION OF THE SERVICE brief overview, including objective of the service Cardiff and Vale University Health Board covers the areas of Cardiff and the Vale of Glamorgan serving a population of around 489,931, which is 15.7% of the population of Wales 1. Of the 2,837 breast malignancies audited during the reporting period or 13.7% of patient were treated within the Health Board. Cardiff and Vale Breast Centre assesses symptomatic patients presenting from the Cardiff and Vale area. In addition, it is part of the Breast Test Wales screening services. The Cardiff and Vale MDT covers all patients from these two routes. The purpose of the MDT is to ensure rapid access to the service for all those requiring a specialist opinion for a breast problem, facilitate multidisciplinary management of patients with breast cancer, newly diagnosed or recurrent, ensuring that the patients experience an efficient service which is of the highest quality and adheres to current clinical guidance. Central to this is the weekly MDT meeting where cases are discussed at diagnosis, following completion of treatment modalities and on suspicion of disease recurrence or progression. The MDT also aims to collect high quality clinical information on its patients to support and inform all of those involved in the patient s care and to allow clinical audit. PATHWAY describe links between primary care, diagnostics, MDT and treatment Cardiff and Vale Breast Centre (C&V-BC) assesses symptomatic patients referred by General Practitioners (GPs) in the C&V area. There are > 400 new referrals/ month. These are referred as USC or Urgent / Routine by GPs using Wales Clinical Portal (WCP) electronic referral service. The team also works closely with Breast Test Wales (BTW) NHS Breast Screening Programme. We provide surgical support for 2 screening clinics / week and some of our radiology team work with BTW as well. This maintains the team s expertise in the diagnosis and management of screen detected problems. 1 Stats Wales: 2 New patients diagnosed from 01 April 2016 to 31 March 2017
3 The Breast Centre provides a diagnostic service for all GP referrals and a treatment service for those who are diagnosed with Breast cancer. The team provides a full range of surgical procedures, including oncoplastic procedures. The team provides follow up for patients who have been treated for breast cancer. We also co-ordinate a service for women in SE Wales, with genetic mutations (about 25 referrals/yr). This involves the All Wales Genetics Service, a Plastic Surgeon from Morriston Hospital, 2 Breast Consultants and a Consultant Nurse. Joint clinics (three monthly) review patients considering risk reducing surgery. The purpose of the MDT is to ensure rapid access to the service for all those requiring a specialist opinion for a breast problem, facilitate multidisciplinary management of patients with Breast cancer, symptomatic or screen detected, newly diagnosed or recurrent, ensuring that the patients experience an efficient service which is of high quality and adheres to current clinical guidance. Central to this is the weekly MDT meeting where cases are discussed at diagnosis, following completion of treatment and on suspicion of disease recurrence or progression. Clinical colleagues from Velindre NHS Trust are key members of the MDT to enable smooth transfer of patients to specialist treatments. The MDT collects clinical information on its patients, to support and inform all those involved in the patient s care and to allow clinical audit. IMPROVEMENTS/CHANGES SINCE LAST REVIEW refer to last Action Plan 1. The Health Board/MDT reported progress to the concerns raised from their peer review of 2015, including: a. Improved resources and support for oncology patients; b. Ratification of the MDT follow up protocol; c. The addition of a breast surgeon and oncologist to the MDT since the last review; d. The use of Canisc MDM module during the MDT in a fully functioning MDT room 2. The MDT reported the completion of seventeen (17) clinical audits or service improvements since the last review. CANCER SERVICE Specifics Diagnosing Cancer Details Referral guidelines for symptomatic patients are based on the NICE guidelines for USC referrals. GP referrals are via Welsh Clinical Portal (WCP), which allows dialogue with a GP if necessary. 28 June
4 Symptomatic patients are assessed by history, clinical examination and imaging - mammograms (from 40 years) and ultrasound if required at their first clinic appointment. Biopsies are performed as required in a triple assessment clinic. All patients who have had a biopsy are discussed at the next MDT and return for results. CT Staging is done preoperatively for patients with stage 3/4 disease, or who have symptoms suggestive of metastatic disease. Postoperatively, staging is done for cancers with > 4 positive axillary nodes. Cardiff & Vale University Health Board do not meet the Urgent Suspected Cancer (USC) target of 95%, but did meet the Non-Urgent Suspected Cancer (NUSC) target of 98%. The Health Board performed as well as other Health Boards in Wales for treating patients efficiently, however the Health Board had the highest average number of days to see patients recording a median of 29 days. During discussion delays in HER2 testing were reported by Health Boards within the region and seen as a sub-optimal delay for patients. The delay affected patients with a HER2 status of 2+ where the sample requires further immunohistochemistry known as FISH (Fluorescence In Situ Hybridization). Treating Cancer Patients diagnosed with cancer are managed according to current NICE guidelines, taking into account pathological characteristics, including ER and HER2 status. Decisions regarding postoperative adjuvant treatments are based on Predict and other algorithms. Oncotype DX is used if indicated as per NICE guidelines. Postoperative radiotherapy is given following breast conservation surgery and to the chest wall and supra-clavicular fossa if the cancer is 5cm or greater and/or where 4 or more lymph nodes are positive. If a patient is found to have possible breast pathology as an incidental finding after other radiological investigations, a referral is sent to the MDT co-ordinator, who alerts the MDT chair and breast team lead to discuss whether the patient needs a clinic appointment or discussion at MDT first. The Acute Oncology team also refer by direct contact or contact, for discussion at MDT and clinical review. Patients with screen detected cancers are diagnosed at BTW and are discussed preoperatively at BTW MDT and postoperatively at C&V. 28 June
5 MDT SERVICE Specifics Local / Regional VC Used with whom? Membership / attendance MDT Charter Observations MDM Module used Details The breast multidisciplinary team (MDT) is a multi-professional team based at University Hospital of Wales Llandough. This is a local MDT that links and works in partnership with the regional cancer centre of Velindre. Video conferencing is not routinely used, specialists in attendance.. The Health Board MDT reported all required members for the MDT and cover arrangements in place. During the MDT visit the following observations were noted: Good leadership. Mutual respect between colleagues. Outcomes are recorded and clinical history provided by notes, not Canisc MDM. Delays with HER2 reporting. Performance status and pre-treatment stage not captured. Staging captured for post op histology patients. Canisc MDM module is used and information is validated during the MDT. However, the MDT did not capture performance status and pre-treatment stage. Post op staging is recorded. Information summary 51 MDT Meetings 23 days Median days to first treatment 388 New diagnosis 33% Screen detected 67% Symptomatic 6.3% Conversion rate 90% USC (62 day target) 98% NUSC (31 day target) 54% Detection rate 3.6% Stage recorded 3 40% Mastectomy 60% Breast conservation 3 Stage recorded refers to pre-treatment stage or radiological stage. The relevant focus for breast teams has been to record post-treatment or pathological stage. 28 June
6 PATIENT CENTRED CARE AND EXPERIENCE Specifics Named Key Worker / contact details Care plans / holistic needs assessment Follow up process Details Named key worker from a point of diagnosis that continues through the patient pathway. Key worker and contact details recorded on all letters and recorded on Canisc. Holistic needs assessments (HNAs) are formally carried out at first assessment and following completion of treatment. The Health Board are also rolling out their ehna programme. Follow up protocol for 10 years where the consultant nurse leads the follow up clinics. Moving Forward courses are also run within the Health Board. SUPPORTIVE CARE Specifics Patient Questionnaire Prehabilitation / Rehabilitation Details Local questionnaire surveys were not discussed, but patient engagement was described within the submission. The Cancer Patient Experience Survey of 2017 was also acknowledged. Through follow up, patients have access to lymphoedema, physiotherapy, welfare and benefit advice, and psychological support. Access to all AHP groups is ad hoc and limited nearer to home, often utilising Velindre Cancer Centre (VCC) for more complex patient. VCC services are currently limited due to staffing. Inequity was highlighted if under a surgeon and not an oncologist. STRATEGIC INTERFACE Specifics Business meeting Details The MDT conducted formal business meetings. Clinicians, through varied membership, communicate through the cancer structure within Cardiff & Vale. 28 June
7 Policy Links to organisational strategy / planning NICE Guidelines; Best practice diagnostic guidelines for patients presenting with breast symptoms; National Guidance for the use of Endocrine Therapy in the Management of Early Breast Cancer; Protocol for Management of Bone Health in post-menopausal ladies starting on Aromatase Inhibitors; Protocol for Primary Hormone Therapy; Cancer Genetics Service for Wales Referral Guidelines. The Health Board have a structure within the organisation and peer review attended by Health Board lead cancer clinician and lead cancer nurse. Cardiff & Vale do not have a designated Cancer Manager, but do have a permanently funded AHP Lead. PATIENT AND STAFF ENGAGEMENT Specifics Patients engagement Staff survey Details In general, patients were very positive and complimentary for the service provision. The MDT have also engaged with patients to capture their views for improvement. Ten (10) Health Board and MDT members completed the staff survey with all positive responses supporting the MDT. GENERAL OBSERVATIONS A Clinical Nurse Specialist Chaired and Led the MDT, which was well supported by the team and works well. Consultant radiographers being used demonstrating a different way of working. Low percentage of screen detected breast cancers managed by the MDT. Access to clinical trials, albeit limited due to Health Board pathology and radiology capacity. 28 June
8 GOOD PRACTICE GOOD PRACTICE AND SIGNIFICANT ACHIEVEMENTS identify any areas of good practice A proactive MDT striving to improve all aspects of the patient pathway with involvement in studies around shared decision making led by the Breast Cancer Nurses. Additional Consultant Surgeon and Consultant Oncologist since last review, which leads to improved cross cover working. Metastatic breast forum at Velindre Cancer Centre. Development of the ehna programme. Consultant nurse roll with both diagnostic and follow up clinics, including service for BRCA patients and counselling. Ward nurses also cover clinics and upskilling of Healthcare Assistants (HCAs). The Health Board announced the permanent funding of the lead Allied Health Professional role. This role led to proactive National Exercise Referral Scheme (NERS) engagement, walking groups, a gym with temporary funding for physiotherapy within the breast centre, musculoskeletal (MSK) links and services with Velindre Cancer Centre including physiotherapy. Moving forward course is also run within the Health Board. IMMEDIATE RISKS TITLE Detail of the risk Rationale None None None SERIOUS CONCERNS TITLE Detail of the risk Rationale None None None 28 June
9 CONCERNS TITLE Detail of the risk Rationale Pathway Performance Pathology service Data quality Radiology service USC performance is at 90% and it takes an average of 29 days to be seen. With a large number of people being referred and patients being managed by the MDT it is a challenge to see, diagnose and treat within the timescales defined by policy. Pathology department is short staffed, including pathologists and biomedical scientists. With much of the service reliant on good will the service is fragile. The pressures on pathology and within the processing lab are reportedly affecting FISH turnaround times from the University Hospital of Wales. This can lead to suboptimal care for patients who would be eligible for neoadjuvant therapy pertuzumab. Assurance should be provided for turnaround times to improve the care of patients within the region. The MDT Charter checklist noted that the MDT did not provide a performance status for recording and that preoperative staging was not always recorded. The MDT should ensure the accurate recording of all data items through validation. The Health Board and MDT are aware of the challenges to recruit consultant radiologists. There is a concern There is a national move to diagnose and treat patients quicker within Wales, which in turn will improve the health and outcomes of patients in Wales. All organisations are working to achieve high performance of these quality measures. Pathological input, provision and support for cancer MDTs is a national problem. The Health Board should continue to improve all aspects of this service where possible. Delays in HER2 status where it affects the MDTs ability to deliver neoadjuvant therapy is sub-optimal care as it may affect patient outcomes. Clinical audit provides a greater understanding and is the basis for any improvement. It is essential to have good quality accurate data to improve Healthcare services through audit. The MDT should ensure data accuracy and record management for all patients under their care. Using the appropriate systems in place. Radiological input, provision and support for cancer MDTs is a national problem. The 28 June
10 CONCERNS TITLE Detail of the risk Rationale Outpatient service / survivorship regarding the lack of succession planning and the ability to provide adequate radiological support with the current establishment of radiologists in the Health Board. The review panel noted a reduction in the availability and clarity of supportive therapeutic services available to breast cancer patients. Health Board should continue to improve all aspects of this service where possible. Continuation of this practice is a challenge to providers. However, enabling people who have had a diagnosis of cancer to continue with their life and recover from their treatment is an important aspect for healthcare services. PEER REVIEW PANEL NAME Position Organisation Damian Heron Network Director Wales Cancer Network Cath Bale Associate Medical Director / Consultant Oncologist Wales Cancer Network / Betsi Cadwaladr University Health Board Marianne Dillon Consultant Surgeon Abertawe Bro Morgannwg University Health Board Wynne Williams Consultant Pathologist Abertawe Bro Morgannwg University Health Board Gill Dazeley Breast Clinical Nurse Specialist Hywel Dda University Health Board Julie Cowling Information Specialist Wales Cancer Network Dana Knoyle Improvement Lead Wales Cancer Network 28 June
11 PEER REVIEW PANEL NAME Position Organisation Jo Horton Allied Health Professional Lead Abertawe Bro Morgannwg University Health Board HEALTH BOARD STAFF AND MULTIDISCIPLINARY TEAM MEMBERS NAME Position Organisation Sumit Goyal Consultant Surgeon Cardiff & Vale University Health Board Tina Bayliss Deputy Director of Operations, Surgery Cardiff & Vale University Health Board Jyoti Bansal Consultant Radiologist Cardiff & Vale University Health Board Cath Marshall Physiotherapy Service Clinical Lead Cardiff & Vale University Health Board Rhisian Otley Assistant Service Manager, Surgery Cardiff & Vale University Health Board Eleri Davies Consultant Surgeon Cardiff & Vale University Health Board Meriel Jenney Assistant Medical Director, Cancer Cardiff & Vale University Health Board Annette Beasley Lead Cancer Nurse Cardiff & Vale University Health Board Alyn Coles Service Improvement Manager Cardiff & Vale University Health Board Ioulia Evangelou Consultant Histopathologist Cardiff & Vale University Health Board Nicola West Consultant Nurse Cardiff & Vale University Health Board Annabel Borley Consultant Oncologist Velindre Cancer Centre 28 June
12 HEALTH BOARD STAFF AND MULTIDISCIPLINARY TEAM MEMBERS NAME Position Organisation Catherine Pembroke Consultant Oncologist Velindre Cancer Centre Helen Sweetland Consultant Surgeon Cardiff & Vale University Health Board Zoe Hilton Research Nurse Cardiff & Vale University Health Board Sharon Chapman Breast Care Nurse Cardiff & Vale University Health Board Grace Uruski Specialist Breast Cancer Nurse Cardiff & Vale University Health Board 28 June
Health Board/Region: All-Wales
Peer Review: Cancer Sub-site: Gynaecology Health Board/Region: All-Wales Cycle: Second Date of review: February 2018 This report describes the findings and themes observed by clinical review panels during
More informationQuality Standards for Diagnosis and Treatment in Breast Units Across Greater Manchester
Quality Standards for Diagnosis and Treatment in Breast Units Across Greater Manchester Greater Manchester Cancer Clinical Director: Mr Mohammed Absar Pathway Manager: Rebecca Price Pathway approval: 24
More informationNational Breast Cancer Audit next steps. Martin Lee
National Breast Cancer Audit next steps Martin Lee National Cancer Audits Current Bowel Cancer Head & Neck Cancer Lung cancer Oesophagogastric cancer New Prostate Cancer - undergoing procurement Breast
More informationCancer Delivery Plan. April Abertawe Bro Morgannwg University Health Board
Cancer Delivery Plan 16 April Abertawe Bro Morgannwg University Health Board Page 1 of 15 1. Background and context Together for Health a Cancer Delivery Plan was published in 2012 and provides a framework
More informationIn this edition: Newsletter Summer How Primary Care can help earlier diagnosis. Improving communication between Primary & Secondary Care
Newsletter Summer 2016 In this edition: How Primary Care can help earlier diagnosis Improving communication between Primary & Secondary Care A new approach to longer term care How primary care is adapting
More informationNational Standards for Acute Oncology Services
Cancer National Specialist Advisory Group National Standards for Acute Oncology Services June 2016 TABLE OF CONTENTS 1. PURPOSE... 2 2. INTRODUCTION... 2 3. STRATEGIC CONTEXT... 4 4. SCOPE OF ACUTE ONCOLOGY
More informationSingle Suspected Cancer Pathway Definitions pathway start date
Single Suspected Cancer Pathway Definitions pathway start date Date: December 2018 Version: 8.0 Wales Cancer Owner: Network and Welsh Government Status Draft 1 P a g e Purpose of Document This document
More informationGuideline for the Diagnosis of Breast Cancer
Guideline for the Diagnosis of Breast Cancer Version History Version Date Brief Summary of Change Issued 2.0 May 2007 Approved by the Governance Committee 2.0 25.11.08 Discussed at the NSSG 2.1 5.12.08
More informationACTION PLAN FOLLOWING THE LUNG CANCER PEER REVIEW
ACTION PLAN FOLLOWING THE LUNG CANCER PEER REVIEW Health Board: Named Health Board contact: Cancer Network: Named contact for Cancer Network: Health Inspectorate Wales contact: Abertawe Bro Morgannwg University
More informationSELF ASSESSMENT REPORT (MULTI-DISCIPLINARY TEAM)
SELF ASSESSMENT REPORT (MULTI-DISCIPLINARY TEAM) Network Trust MDT MDT Lead Clinician ASWCN TAUNTON AND SOMERSET Taunton Lung MDT (11-2C-1) - 2011/12 Dr Sarah Foster Compliance Self Assessment LUNG MDT
More informationSingle Suspected Cancer Pathway Definitions pathway start date
Single Suspected Cancer Pathway Definitions pathway start date Date: March 2018 Version: 1.2.1 Wales Cancer Owner: Network and Welsh Government Status Published 1 P a g e Purpose of Document This document
More informationGuideline for the Management of Patients Suitable for Immediate Breast Reconstruction
Version History Guideline for the Management of Patients Suitable for Immediate Breast Reconstruction Version Summary of change Date Issued 2.0 Endorsed by the Governance Committee 20.02.08 2.1 Circulated
More informationNICE CG 2009 Early and locally advanced breast cancer: diagnosis and treatment
Modernising Follow Up Breast Cancer Tom Crosby Purpose of Follow Up Benefits Offer holistic support for patient post treatment Physical: Psychological: Social: Secondary screening toxicities anxiety re
More informationBriefing Paper. Single Cancer Pathway
Briefing Paper Single Cancer Pathway Author: Tom Crosby, Clinical Director, Wales Cancer Network Owner: Wales Cancer Network Date: 27 th November 2017 Version: 1.0 Publication/ Distribution: Wales Cancer
More informationThe Single Cancer Pathway
The Single Cancer Pathway Background and Case for Change Case for Change (1) Broadly patient experience of cancer services in Wales is good: 93% of patients rate their care as 7/10 or better (WPES) But
More informationLung Cancer 2013 Peer Review All Wales Report
Lung Cancer 2013 Peer Review All Wales Report This publication and other HIW information can be provided in alternative formats or languages on request. There will be a short delay as alternative languages
More informationLCA Lung Clinical Forum. 21 st October 2014
LCA Lung Clinical Forum 21 st October 2014 Welcome Dr Liz Sawicka Chair - LCA Lung Pathway Group Succession planning Dr Kate Haire Consultant in Public Health Medicine, LCA Commissioning Intentions for
More informationCancer Delivery Plan. Interim Progress Report
Cancer Delivery Plan Interim Progress Report Ref: ABMUHB Reporting Period: November 2012 March 2013 Highlights / Key Achievements PC1 PC2 - PC2.4 Director of Public Health (SH) agreed to become member
More informationCork University Hospital - Cork, Ireland
- Cork, Ireland General Information New breast cancer cases treated per year 336 Breast multidisciplinarity team members 25 Radiologists, surgeons, pathologists, medical oncologists, radiotherapists and
More informationPhysical Activity in North Wales
Physical Activity in North Wales Julie A Jones Macmillan Services Effectiveness Lead June 2015 Person Centred Care Mrs Pat Pilkington, Person Centred Care Manager Mrs Jo Garzoni, Health & Well Being Coordinator
More informationSELF ASSESSMENT REPORT (MULTI-DISCIPLINARY TEAM)
SELF ASSESSMENT REPORT (MULTI-DISCIPLINARY TEAM) Network Trust MDT MDT Lead Clinician GMCN ROYAL WOLVERHAMPTON HOSPITALS The Royal Wolverhampton Hospitals Trust Lung MDT (11-2C-1) - 2011/12 Dr Angela Morgan
More informationNational Center of Oncology - Yerevan, Armenia
- Yerevan, Armenia General Information New breast cancer cases treated per year 450 Breast multidisciplinarity team members 13 Radiologists, surgeons, pathologists, medical oncologists, radiotherapists
More informationACTION PLAN FOLLOWING THE LUNG CANCER PEER REVIEW
ACTION PLAN FOLLOWING THE LUNG CANCER PEER REVIEW Health Board: Named Health Board contact: Cancer Network: Named contact for Cancer Network: Health Inspectorate Wales contact: Abertawe Bro Morgannwg University
More informationNational Optimal Lung Cancer Pathways. Dr Sadia Anwar Nottingham University Hospitals NHS Trust Clinical Lead for Lung Cancer
National Optimal Lung Cancer Pathways Dr Sadia Anwar ttingham University Hospitals NHS Trust Clinical Lead for Lung Cancer Overview How NOLCP evolved How it relates to national guidance Pathways Implementation
More informationImproving services for upper GI (OG) cancer Application template (Version 2)
Trust Clinical lead Improving services for upper GI (OG) cancer Application template (Version 2) Managerial lead Date completed 14 June 2013 Barnet & Chase Farm Hospitals NHS Trust Dr Marta Carpani Upper
More informationINTERNAL VALIDATION REPORT (MULTI-DISCIPLINARY TEAM)
INTERNAL VALIDATION REPORT (MULTI-DISCIPLINARY TEAM) Network Trust MDT MVCN EAST AND NORTH HERTFORDSHIRE Mount Vernon Cancer Centre Cancer Network MDT (11-2K-1) - 2011/12 Date Self Assessment Completed
More informationCancer Improvement Plan Update. September 2014
Cancer Improvement Plan Update September 2014 1 Contents Page 1. Introduction 3 2. Key Achievements 4-5 3. Update on Independent Review Recommendations 6-13 4. Update on IST Recommendations 14-15 5. Update
More informationRegional Follow-up Guidelines
Breast Cancer Managed Clinical Network Breast Cancer Regional Follow-up Guidelines Prepared by J McIlhenny/ I Reid Approved by Breast Cancer MCN Advisory Board/ RCCLG Issue date July 2017 Review date July
More informationTitle: From zero to comprehensive Fracture Liaison service (FLS) within existing resources
Best of Health Staff Awards 2010/11 Best of Health Awards 2013 Dr Abhaya Gupta Consultant Physician Hywel Dda Health Board Title: From zero to comprehensive Fracture Liaison service (FLS) within existing
More informationACE Programme SOMERSET INTEGRATED LUNG CANCER PATHWAY. Phases One and Two Final Report
ACE Programme SOMERSET INTEGRATED LUNG CANCER PATHWAY Phases One and Two Final Report July 2017 Introduction This paper presents the learning and actions that have been generated from phase One and Two
More informationTrust Guideline for the inclusion of women at High Risk of Breast Cancer in the NHS Breast Screening Programme
Trust Guideline for the inclusion of women at High Risk of Breast Cancer in the NHS Breast Screening Programme For Use in: By: For: Division responsible for document: Key words: Name and job title of document
More informationNational Standards for Sarcoma Services
National Standards for Sarcoma Services 2009 TABLE OF CONTENTS 1. INTRODUCTION TO THE NATIONAL CANCER STANDARDS...2 2. METHODOLOGY...4 3. FORMAT...4 4. INTRODUCTION TO SARCOMA...5 STANDARDS TOPIC: ORGANISATION...10
More informationJessa Hospital - Hasselt, Belgium
- Hasselt, Belgium General Information New breast cancer cases treated per year 336 Breast multidisciplinarity team members 19 Radiologists, surgeons, pathologists, medical oncologists, radiotherapists
More informationNational Standards for Sarcoma Services 2009
National Standards for Sarcoma Services 2009 Crown copyright July 2010 F1101011 Contents 1. Introduction to the National Cancer Standards 2. Methodology 3. Format 4. Introduction to Sarcoma Standards Topic:
More informationBarlavento Medical Centre - Portimão, Portugal
- Portimão, Portugal General Information New breast cancer cases treated per year 150 Breast multidisciplinarity team members 9 Radiologists, surgeons, pathologists, medical oncologists, radiotherapists
More informationWaterford Regional Hospital - Waterford City, Ireland
- Waterford City, Ireland General Information New breast cancer cases treated per year 200 Breast multidisciplinarity team members 12 Radiologists, surgeons, pathologists, medical oncologists, radiotherapists
More informationNational Cancer Peer Review Sarcoma. Julia Hill Acting Deputy National Co-ordinator
National Cancer Peer Review Sarcoma Julia Hill Acting Deputy National Co-ordinator Improving Outcomes Guidance The Intentions of Improving Outcomes for People with Sarcoma Changes in the provision of care
More informationAPPENDIX 5 OPERATIONAL POLICY UPPER GASTO-INTESTINAL CANCER NETWORK MULTIDISCIPLINARY TEAM
APPENDIX 5 OPERATIONAL POLICY UPPER GASTO-INTESTINAL CANCER NETWORK MULTIDISCIPLINARY TEAM 1. Introduction The National Cancer Standards for Upper GI Cancer Service (2005) states that patients care should
More informationBreast Cancer MultiDisciplinary Approach
Breast Cancer MultiDisciplinary Approach October 30, 2012 Kristi Dolcetti RN, CON, CBPNC-IC OTN Bookings Regional Cancer Care is booking indirect Patient visits for our Multidisciplinary Cancer Conferences
More informationNational Cancer Peer Review Programme
National Cancer Peer Review Programme Julia Hill Acting Deputy National Co-ordinator What is Cancer Peer Review? A quality assurance process for cancer services. An integral part of Improving Outcomes
More informationANNUAL CANCER DELIVERY ACTION PLAN REPORT
AGENDA ITEM 6.4 6 May 2014 ANNUAL CANCER DELIVERY ACTION PLAN REPORT Executive Lead: Medical Director Author: UHB Cancer Lead Clinician/Cancer Lead Manager Contact Details for further information: Maggie
More informationMamma Centrum / Zelený Pruh - Prague, Czech Republic
- Prague, Czech Republic General Information New breast cancer cases treated per year 490 Breast multidisciplinarity team members 29 Radiologists, surgeons, pathologists, medical oncologists, radiotherapists
More informationWales Abdominal Aortic Aneurysm Screening Programme Proposal Paper: The Implementation and Development of Elective Vascular Networks
Wales Abdominal Aortic Aneurysm Screening Programme Proposal Paper: The Implementation and Development of Elective Vascular Networks Authors: Mr Rhys Blake; Mrs Llywela Wilson; Dr Rosemary Fox; Dr Gareth
More informationUPDATE REPORT: POPULATION SCREENING PROGRAMMES IN POWYS. This is a briefing report on the delivery of population screening in Powys
BOARD MEETING 25 JUNE 2014 AGENDA ITEM 3.4 UPDATE REPORT: POPULATION SCREENING PROGRAMMES IN POWYS Report of Director of Public Health and Strategic Planning Paper prepared by Purpose of Paper Principal
More informationPATHWAY MANAGEMENT OF METASTATIC SPINAL CORD COMPRESSION (MSCC) THE CHRISTIE, GREATER MANCHESTER & CHESHIRE
PATHWAY MANAGEMENT OF METASTATIC SPINAL CORD COMPRESSION (MSCC) THE CHRISTIE, GREATER MANCHESTER & CHESHIRE Procedure Reference: Document Owner: Dr V. Misra Version: Accountable Committee: V3 MSCC Network
More informationUniversity Clinical Center Banja Luka, Breast Center - Banja Luka, Bosnia and Herzegovina
- Banja Luka, Bosnia and Herzegovina General Information New breast cancer cases treated per year 245 Breast multidisciplinarity team members 23 Radiologists, surgeons, pathologists, medical oncologists,
More informationHOSPITAL MODELO - LA CORUÑA, Spain
- LA CORUÑA, Spain General Information New breast cancer cases treated per year 150 Breast multidisciplinarity team members 8 Radiologists, surgeons, pathologists, medical oncologists, radiotherapists
More informationAcute Oncology & Chemotherapy Clinical Network Group (CNG)
Acute Oncology & Chemotherapy Clinical Network Group (CNG) Work Programme 2014-2015 Version 1.0 This Work Programme has been agreed by: Title Name Date Agreed AO & Chemotherapy CNG Chair Ernie Marshall
More informationActivity Report April 2012 March 2013
North, South East and West of Scotland Cancer Networks HepatoPancreatoBiliary Cancers National Managed Clinical Network Activity Report April 2012 March 2013 Mr Colin McKay Consultant Surgeon NMCN Clinical
More informationCancer of Unknown Primary Service
Cancer of Unknown Primary Service Dr Maurice Fernando Consultant In Specialist Palliative Care and CUP lead Doncaster and Bassetlaw Hospitals NHS FT Wakefield meeting -14-07-2016 CUP service CUP MDT
More informationAppendix 4 Urology Care Pathways
Appendix 4 Urology Care Pathways Cancer Care Pathways outline the steps and stages in the patient journey from referral through to diagnostics, staging, treatment, follow up, rehabilitation and if applicable
More informationBreast Clinica de la Mama and Italian Hospital - La Plata, Argentina
- La Plata, Argentina General Information New breast cancer cases treated per year 382 Breast multidisciplinarity team members 18 Radiologists, surgeons, pathologists, medical oncologists, radiotherapists
More informationREPORT TO CLINICAL COMMISSIONING GROUP
REPORT TO CLINICAL COMMISSIONING GROUP 12th December 2012 Agenda No. 6.2 Title of Document: Report Author/s: Lead Director/ Clinical Lead: Contact details: Commissioning Model for Dementia Care Dr Aryan
More informationCIG SCP Health Board/Velindre Implementation Plan (Aneurin Bevan University Health Board)
CIG SCP Health Board/Velindre Implementation Plan (Aneurin Bevan University Health Board) 1 Governance, Leadership and Planning a) Describe your SCP Programme Board (or equivalent), its membership and
More informationShared Care Pathway for Soft Tissue Sarcomas Presenting to Site Specialised MDTs. Gynaecological sarcomas Version 1
Shared Care Pathway for Soft Tissue Sarcomas Presenting to Site Specialised MDTs Gynaecological sarcomas Version 1 Background This guidance is to provide direction for the management of patients with sarcomas
More informationFreedom of Information Act Request Physiotherapy Services for Neurological Conditions
Freedom of Information Act Request Physiotherapy Services for Neurological Conditions 1. In total how many physiotherapists does C&V UHB employ? s services 33 qualified paediatric physiotherapy staff in
More informationBreast Unit - University of Heidelberg - Heidelberg, Germany
- Heidelberg, Germany General Information New breast cancer cases treated per year 600 Breast multidisciplinarity team members 17 Radiologists, surgeons, pathologists, medical oncologists, radiotherapists
More informationImproving Outcomes for People with Sarcoma
NHS National Institute for Health and Clinical Excellence Guidance on Cancer Services Improving Outcomes for People with Sarcoma List of All Recommendations March 2006 Developed for NICE by the National
More informationRichard Watson, Chief Transformation Officer. Dr P Holloway, GP Clinical Lead for Cancer Lisa Parrish, Senior Transformation Lead
GOVERNING BODY Agenda Item No. 08 Reference No. IESCCG 18-02 Date. 23 January 2018 Title Lead Chief Officer Author(s) Purpose Cancer Services Update Richard Watson, Chief Transformation Officer Dr P Holloway,
More informationNCIN Breast Cancer Workshop 13 March 2014 Hilton Metropole, NEC, Birmingham. Kieran Horgan, Dick Rainsbury, Mark Sibbering, Gill lawrence
NCIN Breast Cancer Workshop 13 March 2014 Hilton Metropole, NEC, Birmingham Kieran Horgan, Dick Rainsbury, Mark Sibbering, Gill lawrence 1 Interactive Workshop Session Professor Kieran Horgan Workshop
More informationGroote Schuur Academic Hospital - Cape Town, South Africa
- Cape Town, South Africa General Information New breast cancer cases treated per year 400 Breast multidisciplinarity team members 7 Radiologists, surgeons, pathologists, medical oncologists, radiotherapists
More informationSurgical Oncology/Clinical Center Sarajevo - Sarajevo, Bosnia and Herzegovina
- Sarajevo, Bosnia and Herzegovina General Information New breast cancer cases treated per year 200 Breast multidisciplinarity team members 24 Radiologists, surgeons, pathologists, medical oncologists,
More informationActivity Report April 2013 March 2014
North, South East and West of Scotland Cancer Networks Sarcoma National Managed Clinical Network Activity Report April 2013 March 2014 Dr Jeff White Consultant Oncologist NMCN Clinical Lead Lindsay Campbell
More informationINTERNAL VALIDATION REPORT (MULTI-DISCIPLINARY TEAM)
INTERNAL VALIDATION REPORT (MULTI-DISCIPLINARY TEAM) Network Trust MDT NECN N Tees & Hartlepool North Tees And Hartlepool Date Self Assessment Completed 23rd July 2009 Date of IV Review 19th June 2009
More informationCivic Hospital of Sanremo ASL 1 Imperiese - Sanremo, Italy
- Sanremo, Italy General Information New breast cancer cases treated per year 188 Breast multidisciplinarity team members 10 Radiologists, surgeons, pathologists, medical oncologists, radiotherapists and
More informationActivity Report April 2013 March 2014
North, South East and West of Scotland Cancer Networks HepatoPancreatoBiliary Cancers National Managed Clinical Network Activity Report April 2013 March 2014 Mr Colin McKay Consultant Surgeon NMCN Clinical
More informationMasDA Mastectomy Decisions Audit 2015
MasDA Mastectomy Decisions Audit 2015 AUDIT PROTOCOL FULL TITLE Mastectomy Decisions Audit: a prospective, multi-centre, population-based audit SHORT TITLE MasDA CHIEF INVESTIGATORS Mrs Jagdeep K Singh,
More informationGroupe Hospitalier Avicenne-Jean Verdier, CHU de Paris-Seine-Saint-Denis - Bobigny, France
Groupe Hospitalier Avicenne-Jean Verdier, CHU de Paris-Seine-Saint-Denis - Bobigny, France General Information New breast cancer cases treated per year 220 Breast multidisciplinarity team members 13 Radiologists,
More informationLCA Mental Health & Psychological Support Mapping
LCA Mental Health & Psychological Support Mapping November 2013 Contents 1 Introduction... 3 2 Method... 3 3 Results... 3 3.1 Information Centres... 3 3.2 Training and Education... 5 3.3 Level Two Supervision...
More informationFRAILTY PATIENT FOCUS GROUP
FRAILTY PATIENT FOCUS GROUP Community House, Bromley 28 November 2016-10am to 12noon In attendance: 7 Patient and Healthwatch representatives: 4 CCG representatives: Dr Ruchira Paranjape went through the
More informationLung cancer timed clinical pathways
Lung cancer timed clinical pathways December 2017 1 Context This document sets out best practice timed clinical pathways for lung cancer. It is anticipated that all Cancer Alliances will audit against
More informationIppocration Hospital University of Athens - Athens, Greece
- Athens, Greece General Information New breast cancer cases treated per year 250 Breast multidisciplinarity team members 11 Radiologists, surgeons, pathologists, medical oncologists, radiotherapists and
More informationCancer of Unknown Primary (CUP) Protocol
1 Department of Oncology. Cancer of Unknown Primary (CUP) Protocol Version: Document type: Document sponsor Designation Document author [ s] Designation[s] Approving committee / Group Ratified by: Date
More informationCardiff and Vale University Health Board. Specialty Registrar (StR) in Oral Medicine
WALES POSTGRADUATE DENTAL DEANERY 8 th Floor, Neuadd Meirionnydd Heath Park, Cardiff CF14 4YS Cardiff and Vale University Health Board JOB DESCRIPTION Specialty Registrar in Oral Medicine Job Title: Specialty
More informationPEER REVIEW VISIT REPORT (MULTI-DISCIPLINARY TEAM)
PEER REVIEW VISIT REPORT (MULTI-DISCIPLINARY TEAM) Network Organisation (Trust) Team DCN POOLE Poole THYROID ONLY MDT (11-2I-2) - 2011/12 Peer Review Visit Date 18th August 2011 Compliance THYROID ONLY
More informationAthens Euroclinic - Athens, Greece
- Athens, Greece General Information New breast cancer cases treated per year 197 Breast multidisciplinarity team members 12 Radiologists, surgeons, pathologists, medical oncologists, radiotherapists and
More informationGuven Hospital - Ankara, Turkey
- Ankara, Turkey General Information New breast cancer cases treated per year 180 Breast multidisciplinarity team members 9 Radiologists, surgeons, pathologists, medical oncologists, radiotherapists and
More informationCoversheet for Network Site Specific Group Agreed Documentation
Coversheet for Network Site Specific Group Agreed Documentation This sheet is to accompany all documentation agreed by Pan Birmingham Cancer Network Site Specific Groups. This will assist the Network Governance
More informationBreast Cancer Services in Germany
Breast Cancer Services in Germany COUNTRY DELEGATES WORKSHOP Ispra (VA) - 13 and 14 March 2013 Karen Budewig, Federal Ministry of Health, Germany Vanessa Kääb-Sanyal, Mammography-Screening-Program, Germany
More informationDyson Center for Cancer Care - Poughkeepsie, New York, United States of America
- Poughkeepsie, New York, United States of America General Information New breast cancer cases treated per year 323 Breast multidisciplinarity team members 14 Radiologists, surgeons, pathologists, medical
More informationWest Midlands Sarcoma Advisory Group
West Midlands Sarcoma Advisory Group Guideline for the Initial Investigation and Referral to Specialist Sarcoma Multi Disciplinary Team for Suspected Bone Sarcoma Version History Version Date Brief Summary
More informationA06/S(HSS)b Ex-vivo partial nephrectomy service (Adult)
A06/S(HSS)b 2013/14 NHS STANDARD CONTRACT FOR EX-VIVO PARTIAL NEPHRECTOMY SERVICE (ADULT) PARTICULARS, SCHEDULE 2 THE SERVICES, A - SERVICE SPECIFICATION Service Specification No. Service Commissioner
More informationSTANDARDS FOR UPPER GI CANCERS 2004
STANDARDS FOR UPPER GI CANCERS 2004 Source: CSCG Title: UPPER GI CANCERS STANDARDS Version: 10/CONSULTATION Page 1 of 33 1. INTRODUCTION TO THE CANCER STANDARDS 1.1 These Cancer Standards replace the previous
More informationDESIGNED TO TACKLE RENAL DISEASE IN WALES DRAFT 2 nd STRATEGIC FRAMEWORK for
DESIGNED TO TACKLE RENAL DISEASE IN WALES DRAFT 2 nd STRATEGIC FRAMEWORK for 2008-11 1. Aims, Outcomes and Outputs The National Service Framework Designed to Tackle Renal Disease in Wales sets standards
More informationSkull Base Tumour Service. The Multi-Disciplinary Team (MDT) Explained. Jan 2018 v1
Skull Base Tumour Service The Multi-Disciplinary Team (MDT) Explained Jan 2018 v1 Skull base tumours grow in the bones of the skull that form the bottom of the head and the body ridge between the nose
More informationAlexandrovska Hospital - Sofia, Bulgaria
- Sofia, Bulgaria General Information New breast cancer cases treated per year 190 Breast multidisciplinarity team members 8 Radiologists, surgeons, pathologists, medical oncologists, radiotherapists and
More informationRuth Howkins Deputy National Coordinator National Cancer Peer Review
Ruth Howkins Deputy National Coordinator National Cancer Peer Review Purpose of Peer Review To ensure services are as safe as possible To improve the quality and effectiveness of care To improve the patient
More informationUpper GI Cancer Network Site-Specific Group. Work Programme/Service Delivery Plan 2011/14
Upper GI Cancer Network Site-Specific Group Work Programme/Service Delivery Plan 2011/14 1 UPPER GI NSSG Work Programme/Service Delivery Plan AGREEMENT COVER SHEET 2011/14 This Work Programme has been
More informationIntegrated Cancer Services Action Plan. Colchester Hospital University NHS Foundation Trust 31 March 2014
Integrated Cancer Services Action Plan Colchester Hospital University NHS Foundation Trust 31 March KEY Implemented, clearly evidenced and externally approved On Track to deliver Some issues narrative
More informationActivity Report March 2013 February 2014
West of Scotland Cancer Network Skin Cancer Managed Clinical Network Activity Report March 2013 February 2014 Dr Girish Gupta Consultant Dermatologist MCN Clinical Lead Tom Kane MCN Manager West of Scotland
More informationSan Donato Hospital - Azienda USL TOSCANA SUDEST Arezzo - Arezzo, Italy
San Donato Hospital - Azienda USL TOSCANA SUDEST Arezzo - Arezzo, Italy General Information New breast cancer cases treated per year 255 Breast multidisciplinarity team members 18 Radiologists, surgeons,
More informationSELF ASSESSMENT REPORT (MULTI-DISCIPLINARY TEAM)
SELF ASSESSMENT REPORT (MULTI-DISCIPLINARY TEAM) Network Trust MDT MDT Lead Clinician NECN NORTH TEES AND HARTLEPOOL North Tees And Hartlepool Lung MDT (11-2C-1) - 2011/12 Dr D N Leitch Compliance Self
More informationNICE Quality Standards and COF
NICE Quality Standards and COF David Baldwin Consultant Respiratory Physician NUH Hon Senior Lecturer Nottingham University Clinical lead NICE lung cancer GL Chair NICE QS Topic Expert Group Quality Standards
More informationChris Hani Baragwanath Academic Hospital - Johannesburg, South Africa
- Johannesburg, South Africa General Information New breast cancer cases treated per year 355 Breast multidisciplinarity team members 15 Radiologists, surgeons, pathologists, medical oncologists, radiotherapists
More informationNational Optimal Lung Cancer Pathway
National Optimal Lung Cancer Pathway This document was produced by the Lung Clinical Expert Group 2017 Document Title: National Optimal Lung Cancer Pathway and Implementation Guide Date of issue: August
More informationCancer Services Position & Recovery Plan June 2015
Appendix 6 Cancer Services Position & Recovery Plan June 2015 Introduction The Trust is required to achieve 85% compliance for patients on a 62 day pathway from the referral date to the date they receive
More informationBrustzentrum Universitaets Frauenklinik Tuebingen
- Tuebingen, Germany General Information New breast cancer cases treated per year 600 Breast multidisciplinarity team members 16 Radiologists, surgeons, pathologists, medical oncologists, radiotherapists
More informationNHS Rotherham Clinical Commissioning Group
NHS Rotherham Clinical Commissioning Group Operational Executive: 2 nd November 2015 Governing Body: 4 th November 2015 Review of Stroke Care Pathway GP Lead: Dr Phil Birks Lead Executive: Keely Firth
More informationHaematology Advisory Group Meeting
Haematology Advisory Group Meeting 19 November 2003 Meeting Room Velindre NHS Trust Corporate Headquarters Parc Nantgarw Present Dr HW Habboush Chairman Dr A Al-Sabah Consultant Haematologist Cardiff and
More informationHospital Universitari La Fe - Valencia, Spain
- Valencia, Spain General Information New breast cancer cases treated per year 180 Breast multidisciplinarity team members 13 Radiologists, surgeons, pathologists, medical oncologists, radiotherapists
More information